Blood omega-3 fatty acids and death from COVID-19: A pilot study
- PMID: 33516093
- PMCID: PMC7816864
- DOI: 10.1016/j.plefa.2021.102250
Blood omega-3 fatty acids and death from COVID-19: A pilot study
Abstract
Very-long chain omega-3 fatty acids (EPA and DHA) have anti-inflammatory properties that may help reduce morbidity and mortality from COVID-19 infection. We conducted a pilot study in 100 patients to test the hypothesis that RBC EPA+DHA levels (the Omega-3 Index, O3I) would be inversely associated with risk for death by analyzing the O3I in banked blood samples drawn at hospital admission. Fourteen patients died, one of 25 in quartile 4 (Q4) (O3I ≥5.7%) and 13 of 75 in Q1-3. After adjusting for age and sex, the odds ratio for death in patients with an O3I in Q4 vs Q1-3 was 0.25, p = 0.07. Although not meeting the classical criteria for statistical significance, this strong trend suggests that a relationship may indeed exist, but more well-powered studies are clearly needed.
Keywords: COVID-19; Docosahexaenoic acid; Eicosapentaenoic acid; Inflammation; Omega-3 fatty acids; Omega-3 index; Total mortality.
Copyright © 2021 Elsevier Ltd. All rights reserved.
References
-
- World Health Organization Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int/. Last accessed 01/20/2021.
-
- Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239–1242. - PubMed
-
- Calder P.C. Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance. Biochim. Biophys. Acta. 2015;1851:469–484. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
